A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute

Follow up survey for implementation of fixed-dosing of monoclonal antibodies

(2020) Kimberley M. Heinhuis et al.   International Journal of Clinical Pharmacy

Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer center

(2020) Evan Hall et al.   Cancer Medicine

Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?

(2019) Arnaud Bayle et al.   EUROPEAN JOURNAL OF CANCER

Antibodies to watch in 2020

(2019) Hélène Kaplon et al.   mAbs

Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors

(2018) Sarbajit Mukherjee et al.   AMERICAN JOURNAL OF THERAPEUTICS

Antibodies to watch in 2018

(2018) Hélène Kaplon et al.   mAbs

Antibodies to watch in 2019

(2018) Hélène Kaplon et al.   mAbs

Fixed Dosing of Monoclonal Antibodies in Oncology

(2017) Jeroen J.M.A. Hendrikx et al.   ONCOLOGIST

Fixed Dosing Versus Body Size-Based Dosing of Monoclonal Antibodies in Adult Clinical Trials

(2009) Diane D. Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY